Compounding pharmacies are commanding serious attention from buyers, and the reasons are concrete. Demand for customized medications, hormone therapy, and specialty formulations keeps growing as patients and prescribers look beyond mass produced drugs. That rising demand, combined with the specialized capability of a licensed compounding operation, makes these businesses genuinely hard to replicate and therefore valuable. Private equity backed pharmacy platforms and larger operators are actively acquiring compounders to add capacity and clinical reach, and they are paying strong multiples for facilities with clean records and established prescriber relationships. Modern compounding also demands ongoing investment in equipment, quality systems, and staff, so a facility already built to standard is a prize for a buyer who would rather buy than build. A steady prescriber base and diversified revenue can move your figure toward the top of the range. Many founders built these operations over decades and are ready to pass them on. If retirement, easing your day to day involvement, or capturing today elevated valuations is on your mind, this is a favorable moment to sell into that demand.